Childhood Idiopathic Nephrotic Syndrome

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Childhood Idiopathic Nephrotic Syndrome trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT04207580

A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.

Pediatric idiopathic nephrotic syndrome (INS) is a rare disease for which the optimal therapeutic strategy has not yet been defined. A network of clinicians tre…

France1,180 participantsStarted 2020-03-13

Treatment: Inclusion and follow up of pediatric patients with an idiopathic nephrotic syndrome,

RecruitingPhase 3

NCT06635720

REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE)

This is a pilot feasibility study for a proposed full-scale randomized controlled trial to evaluate the effectiveness and safety of a reduced-dose oral predniso…

Canada50 participantsStarted 2024-11-01

Treatment: Prednisone

All recent trials (8 shown)

Active — Not RecruitingPhase 3

NCT05627557

A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic N…

This open-label, randomized multicenter study is to assess the efficacy, safety, and pharmacokinetics (PK)/pharmacodynamics (PD) of obinutuzumab compared with m…

United States85 participantsStarted 2023-03-29

Treatment: Obinutuzumab, MMF

CompletedNot Applicable

NCT04075656

UrApp for Childhood Nephrotic Syndrome Management (Incident Cohort)

Idiopathic nephrotic syndrome is one of the most common chronic kidney diseases in children. Patients suffer from frequent disease relapses and complications. S…

United States58 participantsStarted 2019-09-17

Treatment: Standard of Care, UrApp

Childhood Idiopathic Nephrotic Syndrome

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.

REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE)

All recent trials (8 shown)

A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic N…

UrApp for Childhood Nephrotic Syndrome Management (Incident Cohort)

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.

REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE)

All recent trials (8 shown)

A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic N…

UrApp for Childhood Nephrotic Syndrome Management (Incident Cohort)

Steroid Treatment of Idiopathic Nephrotic Syndrome

Role of Montelukast in Preventing Relapse in Childhood Idiopathic Nephrotic Syndrome

CHILDNEPH The Canadian Childhood Nephrotic Syndrome Study

Efficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During Childhood